Director of Research
Damitha is Director of Research at GT Research. He is an accomplished investor with a demonstrated record of excellence in research, investment management and asset allocation. He is currently ranked 1st out of 10,000 analysts over the last twelve months on SumZero, the world’s largest community of investment professionals working at hedge funds, mutual funds, and private equity funds. His investment ideas and market commentaries have also been featured on Reuters, MSN, and Seeking Alpha. Damitha holds a BSc from the University of Mary Washington and an MBA from Duke University.
Dr. Michael Francis
Chief Science Officer
Dr. Francis is Chief Science Officer at GT Research and Assistant Professor of Physiology and Cell Biology at the University of South Alabama. Dr. Francis is an experienced research scientist with extensive knowledge of molecular biology, research processes and biomedical software and analytics. In addition to participating in Fund management, due diligence and investment decisions, Dr. Francis manages GTR's proprietary bioinformatics and genomics research platform. Dr. Francis earned a BSc in Physics from Auburn University and a PhD in Physiology from the University of South Alabama.
Anthony Campbell brings an established career in scientific product development and strategy consulting to the role of Managing director. Anthony brings tremendous domain expertise in global health sector markets, including research operations management and regulatory compliance strategy. Anthony is well suited to ensure a smooth product development to IP creation pipeline, culminating with the production of viable IP assets.Anthony holds a BSE in Chemical Engineering and Biomedical Engineering from The University of Michigan and an MBA from Duke University, The Fuqua School of Business.
Chief Executive Officer
Sam is Founder and CEO of GTR. He is also Co-Founder of Genesis Block, a blockchain- focused venture production studio. Prior to founding GTR, Sam was an attorney at Debevoise & Plimpton LLP, where he focused his practice on complex financial services regulation. Sam holds a JD from the University of Chicago Law School and a BSE from the Wharton School of the University of Pennsylvania, where he was a Benjamin Franklin Scholar and a Joseph Wharton Scholar.
Jun Hao Tan
Previously a registered pharmacist in Singapore, Jun is an advisor for GT Research. After Jun transitioned into the pharma industry he began working in the Medical Affairs team at Merck before becoming the Quality Assurance Manager at Yourway Transport Biopharma, overseeing the clinical supply operations throughout Asia. In this role, Jun pioneered the validation protocol for the use of Styrofoam boxes in place of expensive credo boxes for cold chain management of vaccine transportation. Jun holds a MBA from Duke University, The Fuqua School of Business
Chief Growth Officer
A long-time investment practitioner and horticulturalist, Danny handles operations, project management, and execution for GTR. His professional experience includes oversight and execution of complex environmental and construction projects. Danny has overseen all aspects of crop production and sale on multi-acre organic farms in California and Montana. He holds a BA in Government and Law and a BA in Spanish from Lafayette College.